Makucell™ Appoints Business and Technology Legal Expert William Eigner to Its Board of Advisors

SCOTTSDALE, Ariz. and LOS ANGELES, March 26, 2012 /PRNewswire-USNewswire/ -- Makucell, Inc., a life science company dedicated to the development, manufacture and distribution of non-prescriptive topical products formulated to address the challenges of aging skin through the direct-to-physician channel has appointed William Eigner, Partner and member of the business and technology team at Procopio, Cory, Hargreaves & Savitch LLP law firm in San Diego and Menlo Park, to a position on its Board of Advisors. Mr. Eigner's practice focuses on angel financing, seed and venture capital, and the financing, governing, operating, buying, selling and merging (M&A) of growing technology and other businesses.

"I am pleased to have the opportunity to work with Makucell's veteran senior management team as they bring the company's science-based products to market," comments Eigner. "It appears that Makucell's proprietary technology is an entirely new and different kind of formulation in the skin care market. I look forward to adding value to this exciting new enterprise."

"Bill brings exceptional counsel and insight to Makucell, not merely his legal expertise but his more than 25 years of working with start-up technology companies," notes Dr. Lawrence Rheins, Makucell's President and Chief Executive Officer. "Makucell's products are based upon the intellectual property of our Asymmtate™ technology platform. Bill's presence on our Advisory Board provides Makucell not only with superior legal and business expertise, but a profound knowledge of the challenges and complexities inherent in the technology start-up arena. With Bill's astute guidance, Makucell will be able to leverage our proprietary technology to its fullest potential as we move through business cycles and expand our product lines."  

Dr. Michael Kahn, Makucell co-founder and Board Chairman and distinguished researcher at the Broad Center for Stem Cell and Regenerative Medicine of the University of Southern California, Keck School of Medicine, adds, "Makucell is incredibly fortunate to have Bill accept a position on our Board of Advisors. He is a distinguished lawyer and business leader with enormous expertise. He will be a valuable asset to our team."

In 2008, 2009, 2010, and 2011, The Daily Transcript recognized Mr. Eigner for his selection by area business attorneys as one of San Diego's top corporate attorneys. Also in 2008 and 2012, San Diego Metropolitan Magazine named Mr. Eigner to its "Movers to Watch" list, calling him "the go-to guy for emerging companies." In 2006, The Daily Transcript selected him as one of San Diego's 120 Top Influentials, "a person whose actions and opinions strongly influence the course of events in San Diego's business community."

Mr. Eigner serves as a director of the San Diego Venture Group and CommNexus. He is a director of the San Diego Police Foundation, and a past director of the San Diego Regional Chamber of Commerce, currently a member of the Chamber's Public Policy Committee. Mr. Eigner serves on the Board of the Mundoval Fund (MUNDX), a publicly traded, global, large-cap, value-oriented mutual fund. He also serves on the Boards of Advisors of Nobel Systems, Blue Wave International, Inc., NewBlue, Inc., Pixon Imaging, Vinculum Communications, Inc., SAAS company eSUB, Inc. and other companies.

About Makucell
Makucell Inc. (www.Makucell.com) is a life science company dedicated to the development, manufacture and distribution of non-prescriptive topical products formulated to address the challenges of aging and photo-damaged skin.  Based on scientific research at the Eli & Edythe

Broad Center for Stem Cell and Regenerative Medicine at University of Southern California's Keck School of Medicine, Makucell's products are formulated to enhance the skin's appearance, making it stronger and more youthful-looking. The company's new proprietary technology,

Asymmtate™, works with an individual's own skin stem cells to maintain cellular differentiation as we age. Makucell has a full portfolio of products in its pipeline directed toward improving the appearance of skin, hair and nails which uses the Asymmtate core technology platform.

For media and investment inquiries, please contact Lawrence Rheins at either [email protected] or 1-855-MAKUCELL.

About USC Stevens Institute for Innovation
The USC Stevens Institute for Innovation (http://stevens.usc.edu) is a university-wide resource in the Office of the Provost at the University of Southern California that helps identify, nurture, protect, and transfer to the market the most exciting innovations from USC. It also provides a central connection for industry seeking cutting-edge innovations in which to invest. As part of this role, the USC Stevens Institute manages the university's intellectual property portfolio stemming from its $560M annual research program. Furthermore, the USC Stevens Institute develops the innovator as well as innovations, through educational programs, community-building events, and showcase opportunities.

Media Contact
Lawrence A. Rheins, President & CEO
[email protected]
1-855-MAKUCELL

SOURCE USC Stevens Institute for Innovation